Albemarle Corporation (NYSE:ALB - Get Free Report)'s stock price gapped up prior to trading on Wednesday . The stock had previously closed at $62.90, but opened at $65.52. Albemarle shares last traded at $64.52, with a volume of 469,407 shares changing hands.
Analysts Set New Price Targets
ALB has been the subject of a number of recent analyst reports. Morgan Stanley reduced their price target on shares of Albemarle from $68.00 to $58.00 and set an "underweight" rating for the company in a research report on Tuesday, May 6th. Wells Fargo & Company reduced their target price on Albemarle from $80.00 to $60.00 and set an "equal weight" rating for the company in a research report on Wednesday, April 9th. UBS Group lowered their price target on Albemarle from $86.00 to $64.00 and set a "neutral" rating on the stock in a report on Monday, April 7th. TD Securities dropped their price target on Albemarle from $115.00 to $65.00 and set a "hold" rating for the company in a research report on Thursday, May 1st. Finally, Truist Financial decreased their price objective on shares of Albemarle from $85.00 to $65.00 and set a "hold" rating on the stock in a research report on Monday, April 14th. Three investment analysts have rated the stock with a sell rating, fourteen have issued a hold rating and five have assigned a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of "Hold" and an average target price of $91.62.
Read Our Latest Analysis on ALB
Albemarle Stock Up 4.3%
The company has a market capitalization of $7.72 billion, a P/E ratio of -5.91 and a beta of 1.63. The company has a debt-to-equity ratio of 0.39, a current ratio of 2.11 and a quick ratio of 1.26. The company has a 50 day moving average of $59.44 and a 200-day moving average of $71.74.
Albemarle (NYSE:ALB - Get Free Report) last issued its quarterly earnings data on Wednesday, April 30th. The specialty chemicals company reported ($0.18) earnings per share for the quarter, topping analysts' consensus estimates of ($0.62) by $0.44. The firm had revenue of $1.08 billion for the quarter, compared to analyst estimates of $1.18 billion. Albemarle had a negative return on equity of 1.92% and a negative net margin of 22.39%. The business's quarterly revenue was down 20.9% compared to the same quarter last year. During the same period last year, the company earned $0.26 EPS. As a group, equities analysts anticipate that Albemarle Corporation will post -0.04 EPS for the current year.
Albemarle Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Tuesday, July 1st. Stockholders of record on Friday, June 13th were given a $0.405 dividend. The ex-dividend date was Friday, June 13th. This represents a $1.62 annualized dividend and a dividend yield of 2.47%. Albemarle's dividend payout ratio is -14.57%.
Hedge Funds Weigh In On Albemarle
Several hedge funds and other institutional investors have recently modified their holdings of the stock. Assetmark Inc. boosted its position in Albemarle by 340.6% during the 4th quarter. Assetmark Inc. now owns 304 shares of the specialty chemicals company's stock valued at $26,000 after acquiring an additional 235 shares in the last quarter. SJS Investment Consulting Inc. bought a new stake in shares of Albemarle during the first quarter valued at approximately $32,000. National Pension Service boosted its position in shares of Albemarle by 74.5% during the first quarter. National Pension Service now owns 452 shares of the specialty chemicals company's stock valued at $33,000 after purchasing an additional 193 shares in the last quarter. Pilgrim Partners Asia Pte Ltd purchased a new stake in Albemarle in the fourth quarter worth $34,000. Finally, Orion Capital Management LLC bought a new position in Albemarle in the fourth quarter worth $35,000. Hedge funds and other institutional investors own 92.87% of the company's stock.
About Albemarle
(
Get Free Report)
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Energy Storage, Specialties and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Albemarle, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Albemarle wasn't on the list.
While Albemarle currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.